DDX39 acts as a suppressor of invasion for bladder cancer

Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines

(2010) Shigeru Sakano et al.   BJU INTERNATIONAL

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity

(2010) B. Kumar et al.   CANCER RESEARCH

p53 immunohistochemistry in bladder cancer—a new approach to an old question

(2010) Peter J. Goebell et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Bikunin Loss in Urine as Useful Marker for Bladder Carcinoma

(2009) Ke-Hung Tsui et al.   JOURNAL OF UROLOGY

Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples

(2008) Ke-hung TSUI et al.   ACTA PHARMACOLOGICA SINICA

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

(2008) Marko Babjuk et al.   EUROPEAN UROLOGY

Protein Expression Patterns of Ezrin Are Predictors of Progression in T1G3 Bladder Tumours Treated with Nonmaintenance Bacillus Calmette-Guérin

(2008) Joan Palou et al.   EUROPEAN UROLOGY

Comparative Proteomics Analysis of Vascular Smooth Muscle Cells Incubated withS- andR-Enantiomers of Atenolol Using iTRAQ-coupled Two-dimensional LC-MS/MS

(2008) Jianjun Sui et al.   MOLECULAR & CELLULAR PROTEOMICS

Differential Plasma Glycoproteome of p19ARF Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform

(2008) Simon Letarte et al.   Clinical Proteomics